Enhancement of electrical stability of acutely ischemic myocardium by edrophonium.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D003327:Coronary Disease / Q000503:physiopathology*; D004056:Differential Threshold; D004285:Dogs; D004491:Edrophonium / Q000494:pharmacology*; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D004594:Electrophysiology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006352:Heart Ventricles / Q000294:innervation; D007511:Ischemia / Q000503:physiopathology; D009203:Myocardial Infarction / Q000150:complications; D009206:Myocardium / Q000201:enzymology; D014630:Vagus Nerve / Q000187:drug effects; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control
D002800:Cholinesterase Inhibitors; D004491:Edrophonium; D001285:Atropine; D000109:Acetylcholine